UNSPSC 85613139: Removal of radioactive element from pancreatic duct, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to removal of radioactive element from pancreatic duct, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0FPD31Z

UNSPSC 85613139 Removal of radioactive element from pancreatic duct, percutaneous approach shows little relevant recent activity in state and local procurement. The Commodity code, which nominally describes a specific medical procedure, does not align with the state and local solicitations currently tagged to it. Recent opportunities under this code span occupational medical surveillance, pharmacy benefit management, independent medical evaluations for public safety pension boards, surgical carve-out networks for municipal health plans, specialty and emergency medical services in detention facilities, and temporary health professional staffing — none of which involve removal of radioactive material from pancreatic ducts or percutaneous interventional radiology procedures.

The mismatch suggests that the code has been misapplied to healthcare administration and staffing procurement rather than to the clinical intervention it nominally describes. Issuers include state departments (Washington State Department of Transportation, via Washington State Ferries), counties (Harris County, Collier County, Santa Clara County), cities (Phoenix, Long Beach), and health systems. Geographic spread extends across Washington, Arizona, California, Florida, and Texas. Representative recent opportunities include the City of Phoenix Retirement Office RFP for independent medical evaluation services due October 16, 2026 (Arizona), the Washington State Department of Transportation RFP for occupational medical surveillance due October 9, 2026 (Washington), and the Collier County RFP for pharmacy benefit management services with a historical annual spend of approximately $8.7 million. Vendors evaluating pursuit should verify the actual scope of a given solicitation before assuming alignment with the code's nominal description.